Format
Sort by
Items per page

Send to

Choose Destination

Best matches for malignant neoplasm of prostate AND mortality vital statistics AND prostate cancer screening:

Search results

Items: 1 to 20 of 4503

1.

Student Corner.

Huntington H.

Contemp Nurse. 1994 Sep;3(3):127-130. doi: 10.5172/conu.3.3.127.

PMID:
29134895
2.

Global, Regional and National Burden of Prostate Cancer, 1990 - 2015: Results from the Global Burden of Disease Study 2015.

Pishgar F, Ebrahimi H, Moghaddam SS, Fitzmaurice C, Amini E.

J Urol. 2017 Nov 9. pii: S0022-5347(17)77883-4. doi: 10.1016/j.juro.2017.10.044. [Epub ahead of print]

PMID:
29129779
3.

[COCHRANE SYSTEMATIC REVIEWS ON PROSTATE CANCER].

Vrdoljak D.

Acta Med Croatica. 2016 Dec;70(4-5):257-62. Croatian.

PMID:
29087141
4.

Estimation of the Most Influential Factors for Survival Probability Prediction of Prostate Cancer Patients.

Stanković J, Stanković M.

Cancer Invest. 2017 Oct 21;35(9):594-600. doi: 10.1080/07357907.2017.1385791. Epub 2017 Oct 24.

PMID:
29064739
5.

Lack of Benefit From the Addition of External Beam Radiation Therapy to Brachytherapy for Intermediate- and High-risk Prostate Cancer.

Yang DD, Muralidhar V, Nguyen PL, Buzurovic I, Martin NE, Mouw KW, Devlin PM, Trinh QD, Orio PF 3rd, King MT.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):904-911. doi: 10.1016/j.ijrobp.2017.07.034. Epub 2017 Jul 31.

PMID:
29063853
6.

Biochemical recurrence after radical prostatectomy: what does it mean?

Tourinho-Barbosa R, Srougi V, Nunes-Silva I, Baghdadi M, Rembeyo G, Eiffel SS, Barret E, Rozet F, Galiano M, Cathelineau X, Sanchez-Salas R.

Int Braz J Urol. 2017 Oct 17;43. doi: 10.1590/S1677-5538.IBJU.2016.0656. [Epub ahead of print]

PMID:
29039897
7.

Barriers and facilitators to healthy lifestyle and acceptability of a dietary and physical activity intervention among African Caribbean prostate cancer survivors in the UK: a qualitative study.

Er V, Lane JA, Martin RM, Persad R, Chinegwundoh F, Njoku V, Sutton E.

BMJ Open. 2017 Oct 15;7(10):e017217. doi: 10.1136/bmjopen-2017-017217.

8.

Modified risk stratification grouping using standard clinical and biopsy information for patients undergoing radical prostatectomy: Results from SEARCH.

Zumsteg ZS, Chen Z, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Spratt DE, Sandler HM, Freedland SJ.

Prostate. 2017 Dec;77(16):1592-1600. doi: 10.1002/pros.23436. Epub 2017 Oct 10.

PMID:
28994485
9.

Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer.

Obata H, Shiota M, Akitake N, Takeuchi A, Kashiwagi E, Dejima T, Kiyoshima K, Inokuchi J, Tatsugami K, Eto M.

Anticancer Res. 2017 Oct;37(10):5631-5637.

PMID:
28982880
10.

Both High and Low Serum Total Testosterone Levels Indicate Poor Prognosis in Patients with Prostate Cancer.

Izumi K, Shigehara K, Nohara T, Narimoto K, Kadono Y, Mizokami A.

Anticancer Res. 2017 Oct;37(10):5559-5564.

PMID:
28982870
11.

Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in extracellular vesicles (EV) from prostate cancer patients.

Khan S, Simpson J, Lynch JC, Turay D, Mirshahidi S, Gonda A, Sanchez TW, Casiano CA, Wall NR.

PLoS One. 2017 Oct 5;12(10):e0183122. doi: 10.1371/journal.pone.0183122. eCollection 2017.

12.

Impact of five-tiered Gleason grade groups on prognostic prediction in clinical stage T3 prostate cancer undergoing high-dose-rate brachytherapy.

Tsumura H, Ishiyama H, Tabata KI, Katsumata H, Kobayashi M, Ikeda M, Kurosaka S, Fujita T, Kitano M, Satoh T, Yanagisawa N, Hayakawa K, Iwamura M.

Prostate. 2017 Nov;77(15):1520-1527. doi: 10.1002/pros.23430. Epub 2017 Sep 14.

PMID:
28905446
13.

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.

Tsodikov A, Gulati R, Heijnsdijk EAM, Pinsky PF, Moss SM, Qiu S, de Carvalho TM, Hugosson J, Berg CD, Auvinen A, Andriole GL, Roobol MJ, Crawford ED, Nelen V, Kwiatkowski M, Zappa M, Luján M, Villers A, Feuer EJ, de Koning HJ, Mariotto AB, Etzioni R.

Ann Intern Med. 2017 Oct 3;167(7):449-455. doi: 10.7326/M16-2586. Epub 2017 Sep 5.

PMID:
28869989
14.

Risk of Alzheimer's Disease Among Senior Medicare Beneficiaries Treated With Androgen Deprivation Therapy for Prostate Cancer.

Baik SH, Kury FSP, McDonald CJ.

J Clin Oncol. 2017 Oct 20;35(30):3401-3409. doi: 10.1200/JCO.2017.72.6109. Epub 2017 Aug 25.

PMID:
28841388
15.

[A Case of Pulmonary Tumor Thrombotic Microangiopathy in Castration-Resistant Prostate Cancer].

Hattahara K, Hamada A, Oyama R, Masui K, Shichiri Y.

Hinyokika Kiyo. 2017 Jul;63(7):275-278. doi: 10.14989/ActaUrolJap_63_7_275. Japanese.

PMID:
28814708
16.

Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer.

Larsen SB, Dehlendorff C, Skriver C, Dalton SO, Jespersen CG, Borre M, Brasso K, Nørgaard M, Johansen C, Sørensen HT, Hallas J, Friis S.

J Clin Oncol. 2017 Oct 10;35(29):3290-3297. doi: 10.1200/JCO.2016.71.8981. Epub 2017 Aug 14.

PMID:
28806117
17.

Prostate and breast cancer in four Nordic countries: A comparison of incidence and mortality trends across countries and age groups 1975-2013.

Kvåle R, Myklebust TÅ, Engholm G, Heinävaara S, Wist E, Møller B.

Int J Cancer. 2017 Dec 1;141(11):2228-2242. doi: 10.1002/ijc.30924. Epub 2017 Aug 26.

PMID:
28795403
18.

Diagnostic characteristics of lethal prostate cancer.

Helgstrand JT, Røder MA, Klemann N, Toft BG, Brasso K, Vainer B, Iversen P.

Eur J Cancer. 2017 Oct;84:18-26. doi: 10.1016/j.ejca.2017.07.007. Epub 2017 Aug 2.

PMID:
28779631
19.

Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.

Duchesne GM, Woo HH, King M, Bowe SJ, Stockler MR, Ames A, D'Este C, Frydenberg M, Loblaw A, Malone S, Millar J, Tai KH, Turner S.

Lancet Oncol. 2017 Sep;18(9):1192-1201. doi: 10.1016/S1470-2045(17)30426-6. Epub 2017 Jul 28.

PMID:
28760403
20.

Leukocyte telomere length and renal cell carcinoma survival in two studies.

Callahan CL, Schwartz K, Ruterbusch JJ, Shuch B, Graubard BI, Lan Q, Cawthon R, Baccarelli AA, Chow WH, Rothman N, Hofmann JN, Purdue MP.

Br J Cancer. 2017 Aug 22;117(5):752-755. doi: 10.1038/bjc.2017.237. Epub 2017 Jul 25.

PMID:
28742796

Supplemental Content

Loading ...
Support Center